Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O A Statsenko
G M Usov

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|August 18, 2021
[Agoraphobia with panic disorder combined with depression]O A Statsenko, G M Usov
Experimental Oncology|January 29, 2011
Caspase-3 activity in papillary thyroid carcinomasT M Mishunina, O V Kalinichenko, M D Tronko, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|August 30, 2021
[Dual diagnosis: depression and alcohol use disorder]Y P Sivolap, E M Krupitsky, V D Mendelevich, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|January 17, 2017
[The differences in the estimation of depression severity by psychiatrists and patients during the combined treatment with agomelatine (a multicenter study "EMOTSIA")]V E Medvedev, K Yu Retiunsky, A A Ovchinnikov, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|August 18, 2021
[Agoraphobia with panic disorder combined with depression]O A Statsenko, G M Usov
Experimental Oncology|January 29, 2011
Caspase-3 activity in papillary thyroid carcinomasT M Mishunina, O V Kalinichenko, M D Tronko, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|August 30, 2021
[Dual diagnosis: depression and alcohol use disorder]Y P Sivolap, E M Krupitsky, V D Mendelevich, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|January 17, 2017
[The differences in the estimation of depression severity by psychiatrists and patients during the combined treatment with agomelatine (a multicenter study "EMOTSIA")]V E Medvedev, K Yu Retiunsky, A A Ovchinnikov, et al.
Pageof 1